Actively Recruiting

Phase Not Applicable
Age: 50Years - 80Years
MALE
ID06983444

Bipolar Transurethral Resection Versus Bipolar Enucleation of the Prostate for Treatment of Benign Prostatic Hyperplasia: A Randomized Comparative Study

Led by South Valley University · Updated on 2025-05-21

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness and safety of two surgical methods for treating benign prostatic hyperplasia (BPH), a condition causing lower urinary tract symptoms due to prostate enlargement. The study compares the long-standing standard method, transurethral resection of the prostate (TURP), with a newer approach called bipolar transurethral enucleation of the prostate (TUEP). TURP has been effective but carries risks such as serious complications and longer hospital stays, prompting exploration of safer, minimally invasive options. The trial involves two treatment groups: one receiving TURP and the other receiving bipolar enucleation (TUEP). Both procedures use bipolar diathermy via cystoscopy and are performed under spinal or general anesthesia according to usual care. TURP removes excess prostate tissue piece by piece, whereas TUEP anatomically enucleates the prostate. The study will assess these treatments over at least six months to one year to understand differences in symptom relief and safety. Participants will be men aged 50 to 80 years with significant urinary symptoms and prostate enlargement requiring surgery. Researchers will monitor catheter use, urinary symptoms, operative time, complications, and quality of life using various questionnaires during follow-up visits. Outcomes such as catheter-free status and symptom scores will be evaluated up to one year after surgery to compare the treatments' benefits and risks.

CONDITIONS

Brief Title

Bipolar Resection vs Enucleation of Prostate

Who Can Participate

Age: 50Years - 80Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with lower urinary tract symptoms due to benign prostatic hyperplasia
  • International prostate symptom score (IPSS) greater than 8
  • Maximal urinary flow rate (Qmax) less than 10 ml/second
  • Prostate volume between 60 and 100 grams
  • Indication for surgical intervention
  • Age between 50 and 80 years old
Not Eligible

You will not qualify if you...

  • Presence of prostate cancer
  • Presence of bladder cancer
  • Urethral stricture
  • Neurogenic bladder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - 60 to 90 minutes for surgery plus hospital stay duration

Participants receive either bipolar transurethral resection of the prostate (TURP) or bipolar transurethral enucleation of the prostate (TUEP) performed under spinal or general anesthesia as per usual care. This stage includes the surgery and immediate recovery period.

1 surgery visit and hospital stay

Post-operative Follow-up

Duration - At least 6 months up to one year

Participants are monitored to assess catheter removal, urinary symptoms, complications, and quality of life after surgery.

Multiple follow-up visits over 6 to 12 months

Trial Site Locations

Total: 1 location

1

Faculty of Medicine South Valley University

Qina, Qena Governorate, Egypt, 83523

Actively Recruiting

Loading map...

Research Team

A

AHMED A.FATAH HAMED, Master's

M

Mostafa A.Razik Ahmed, Doctorate

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

The Association of Urinary BDNF and NGF With Lower Urinary S...

Benign Prostatic Hyperplasia With Outflow Obstruction

Actively Recruiting

1 location

Comparison Between Water Vapor Thermal Therapy and Prostatic...

Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

Actively Recruiting

1 location

Preoperative Pelvic Floor Physical Therapy to Minimize Stres...

Benign Prostatic Hyperplasia With Outflow Obstruction

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.

Yucong Zhang, Penghui Yuan, Delin Ma...

https://pubmed.ncbi.nlm.nih.gov/30816336

The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up.

Michael Seitz, Ronald Sroka, Christian Gratzke...

https://pubmed.ncbi.nlm.nih.gov/17628326

Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.

Alexander Bachmann, Leander Schürch, Robin Ruszat...

https://pubmed.ncbi.nlm.nih.gov/16126327

Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years.

Peter J Gilling, Liam C Wilson, Colleen J King...

https://pubmed.ncbi.nlm.nih.gov/21883820

Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis.

Davide Arcaniolo, Celeste Manfredi, Alessandro Veccia...

https://pubmed.ncbi.nlm.nih.gov/31346761

A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system.

Henry S S Ho, Sidney K H Yip, Kok B Lim...

https://pubmed.ncbi.nlm.nih.gov/17416453